RT Journal Article
SR Electronic
T1 The impact of the COVID-19 pandemic on quality of life, physical and psychosocial wellbeing in breast cancer patients and survivors – a prospective, multicenter cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.26.20140657
DO 10.1101/2020.06.26.20140657
A1 Claudia A Bargon CA
A1 Marilot CT Batenburg
A1 Lilianne E van Stam
A1 Dieuwke R Mink van der Molen
A1 Iris E van Dam
A1 Femke van der Leij
A1 Inge O Baas
A1 Miranda F Ernst
A1 Wiesje Maarse
A1 Nieke Vermulst
A1 Ernst JP Schoenmaeckers
A1 Thijs van Dalen
A1 Rhodé M Bijlsma
A1 Danny A Young-Afat
A1 Annemiek Doeksen
A1 Helena M Verkooijen
A1 UMBRELLA study group
YR 2020
UL http://medrxiv.org/content/early/2020/06/28/2020.06.26.20140657.abstract
AB Purpose The COVID-19 pandemic and the resulting social distancing and lockdown measures are having a substantial impact on daily life and medical management of people with breast cancer. We evaluated to what extent these changes have affected quality of life and physical, and psychosocial wellbeing of people (being) treated for breast cancer.Methods This study was conducted within the prospective Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaluation (UMBRELLA). Shortly after the implementation of COVID-19 measures, extra questionnaires were sent to 1595 cohort participants, including standard UMBRELLA quality of life (EORTC) questionnaires. Patient-reported outcomes (PROs) were compared to the most recent PROs collected within UMBRELLA before COVID-19. The impact of COVID-19 on PROs was evaluated using mixed models analysis.Results In total, 1051 patients (66%) completed the questionnaires. One third (n = 327, 31%) reported a higher threshold to contact their general practitioner due to COVID-19. A significant deterioration in emotional functioning was observed (82·6 to 77·9, p < 0.001) and 505 (48%, 95% CI 45-51) patients reported moderate to severe loneliness. Small significant improvements were observed in QoL, physical-, social- and role functioning scores. In the subgroup of 51 patients under active treatment, there was a strong deterioration in social functioning (69·8 to 5·0, p = 0·03).Conclusion Due to COVID-19, patients (being) treated for breast cancer are less likely to contact physicians, and experience a deterioration in emotional functioning. Patients undergoing active treatment report a strong drop in social functioning. One in two patients reports (severe) loneliness. Online applications facilitating peer contact and e-mental health interventions could support mental health and social interaction times of total lockdown or social distancing.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02839863Funding StatementThe authors received no financial support for the research (including study design; data collection, analysis, interpretation of data; and writing of the report), authorship, and/ or (the decision to submit the article for) publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Medical Ethics Committee of the UMCU (NL52651.041.15, METC 15/165)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, upon reasonable request.BMIBody Mass IndexCFCognitive functioning (EORTC-QLQ30 subdomain)CI95% Confidence IntervalCOVID-19COronaVIrus Disease 2019DCISDuctal carcinoma in situEFEmotional functioning (EORTC-QLQ30 subdomain)EORTCEuropean Organization for Research and Treatment of CancerHADSHospital Anxiety and Depression ScaleIQRInterquartile rangeMDMean DifferenceMETCMedical Ethics Research Committee (Dutch: Medisch Ethische Toetsingscommissie)nnumberNKRNetherlands Cancer RegistryPFPhysical functioning (EORTC-QLQ30 subdomain)PRO(s)Patient reported outcome(s)QoLQuality of LifeRFRole functioning (EORTC-QLQ30 subdomain)SDStandard deviationSFSocial functioning (EORTC-QLQ30 subdomain)SPSSStatistical Package for Social SciencesSTROBESTrengthening the Reporting of OBservational studies in EpidemiologyUMBRELLAUtrecht cohort for Multiple BREast cancer intervention studies and Long-term evaluationUMCUUniversity Medical Center UtrechtWHOWorld Health Organization